Jingxuan Wu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants.
Journal: Clinical and translational science
Published: December 07, 2025
Unravelling the human disposition of [14C]-vebreltinib: Faecal recovery of parent drug and a major circulating metabolite defines its mass balance profile.
Journal: British journal of clinical pharmacology
Published: December 01, 2025
Safety, immunogenicity, persistence and dose evaluation of the CS-2034 mRNA COVID-19 vaccine: a phase II randomized controlled trial in healthy Chinese adults.
Journal: BMC infectious diseases
Published: August 10, 2025
Development of a novel tyrosine kinase 2 inhibitor ARTS-011 and its first-in-human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects.
Journal: British journal of pharmacology
Published: June 25, 2025
Trends in drug-drug interactions for new drug clinical trials in China over the past 10 years (2013-2022).
Journal: BMC pharmacology & toxicology
Published: January 16, 2025
A Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT-101, an RNAi Therapeutic Targeting HBV Infection.
Journal: Clinical pharmacology in drug development
Published: December 11, 2024
Development of a novel UHPLC-MS/MS method for quantitative analysis of pirtobrutinib in rat plasma: application to pharmacokinetic study.
Journal: BMC chemistry
Published: October 31, 2024
Immunothrombosis: A bibliometric analysis from 2003 to 2023.
Journal: Medicine
Published: September 17, 2024
Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects.
Journal: Drug design, development and therapy
Published: June 05, 2024
Family guidance regarding internet mitigates older adults' ehealth literacy inequality due to educational attainment through internet use.
Journal: Geriatric nursing (New York, N.Y.)
Published: April 13, 2024
Evaluation of drug-drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjects.
Journal: Clinical and translational science
Published: April 10, 2024
Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.
Journal: The Journal of infection
Published: August 01, 2023
Last Updated: 09/26/2026